
Professor Leonardo Roever
Universidade de Sao Paulo, Uberlandia (Brazil)
Biography
Professor Dr. Leonardo Roever is a clinical epidemiologist, health data scientist, evidence synthesis methodologist, and senior scientific editor with international experience, possessing extensive expertise in clinical research, evidence-based healthcare, biostatistics, systematic reviews and meta-analyses and global health. He graduated from UNIT (2002), completed specializations at UNIFESP (2003) and UFU (2020), obtained a Master's degree (2008) and a Doctorate (2019) in Health Sciences from UFU, completed postdoctoral studies in Neuroscience (USP, 2021), Psychiatry (USP, 2023), Health Sciences (UFU, 2023), and MBA in Data Science and Analytics from USP (2022). Prof. Roever is the author or co-author of over 410 peer-reviewed publications, including articles in prestigious journals such as *The Lancet*, *BMJ, *Nature*, *Nature Medicine*, *JAMA*, *The Lancet Neurology*, *The Lancet Diabetes & Endocrinology*, *The Lancet Respiratory Medicine*, *The Lancet Psychiatry* and others.
Contributor content
Journal
Lifelong impact of adiposity on cardiac structure and function: an alarming signal
16 July 2024
Journal
High visit-to-visit cholesterol variability predicts heart failure and adverse cardiovascular events: a population-based cohort study<sup> </sup>
3 June 2022
Journal
Trends in cardiovascular disease in Australia and in the world
29 August 2020
Journal
Impact of pro-atrial natriuretic peptide in atrial fibrillation and stroke
29 August 2020
Journal
Improvement of LDL cholesterol target achievement rates through cardiac rehabilitation after myocardial infarction
29 August 2020
Journal
Walking or cycling to work to prevent myocardial infarction: Hope or hype?
29 August 2020
Journal
Arterial stiffness in preschool children
29 August 2020
Journal
Subjective assessment of functional capacity to predict postoperative myocardial injury and death: Hope or hype?
25 March 2020
Journal
Admission glucagon-like peptide-1 levels in acute myocardial infarction: is this a new biomarker of cardiovascular risk?
13 December 2019


